Diabetes Mellitus, Experimental
"Diabetes Mellitus, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.
MeSH Number(s)
C18.452.394.750.074
C19.246.240
E05.598.500.374
Concept/Terms
Streptozotocin Diabetes- Streptozotocin Diabetes
- Diabetes, Streptozotocin
- Streptozocin Diabetes
- Diabete, Streptozocin
- Diabetes, Streptozocin
- Streptozocin Diabete
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Experimental".
This graph shows the total number of publications written about "Diabetes Mellitus, Experimental" by people in Harvard Catalyst Profiles by year, and whether "Diabetes Mellitus, Experimental" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 11 | 4 | 15 |
| 1994 | 11 | 3 | 14 |
| 1995 | 9 | 2 | 11 |
| 1996 | 18 | 2 | 20 |
| 1997 | 9 | 3 | 12 |
| 1998 | 7 | 2 | 9 |
| 1999 | 11 | 7 | 18 |
| 2000 | 5 | 2 | 7 |
| 2001 | 18 | 8 | 26 |
| 2002 | 15 | 7 | 22 |
| 2003 | 11 | 10 | 21 |
| 2004 | 15 | 8 | 23 |
| 2005 | 18 | 5 | 23 |
| 2006 | 11 | 8 | 19 |
| 2007 | 12 | 7 | 19 |
| 2008 | 18 | 10 | 28 |
| 2009 | 10 | 12 | 22 |
| 2010 | 20 | 6 | 26 |
| 2011 | 13 | 11 | 24 |
| 2012 | 17 | 9 | 26 |
| 2013 | 20 | 12 | 32 |
| 2014 | 14 | 7 | 21 |
| 2015 | 24 | 7 | 31 |
| 2016 | 18 | 6 | 24 |
| 2017 | 18 | 11 | 29 |
| 2018 | 18 | 10 | 28 |
| 2019 | 14 | 8 | 22 |
| 2020 | 12 | 16 | 28 |
| 2021 | 15 | 9 | 24 |
| 2022 | 14 | 1 | 15 |
| 2023 | 11 | 0 | 11 |
Below are the most recent publications written about "Diabetes Mellitus, Experimental" by people in Profiles.
-
Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients. J Clin Invest. 2023 10 16; 133(20).
-
Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice. J Clin Invest. 2023 07 03; 133(13).
-
VEGFR-2 adhesive nanoprobes reveal early diabetic retinopathy in vivo. Biosens Bioelectron. 2023 Oct 01; 237:115476.
-
The impact of donor diabetes on corneal transplant immunity. Am J Transplant. 2023 09; 23(9):1345-1358.
-
Impaired angiogenesis in diabetic critical limb ischemia is mediated by a miR-130b/INHBA signaling axis. JCI Insight. 2023 05 22; 8(10).
-
Stomach-derived human insulin-secreting organoids restore glucose homeostasis. Nat Cell Biol. 2023 05; 25(5):778-786.
-
A miRNA/CXCR4 signaling axis impairs monopoiesis and angiogenesis in diabetic critical limb ischemia. JCI Insight. 2023 04 10; 8(7).
-
A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes. Nat Cell Biol. 2023 04; 25(4):565-578.
-
Methylcellulose colony assay and single-cell micro-manipulation reveal progenitor-like cells in adult human pancreatic ducts. Stem Cell Reports. 2023 03 14; 18(3):618-635.
-
Protocol for xenotransplantation of human skin and streptozotocin diabetes induction in immunodeficient mice to study impaired wound healing. STAR Protoc. 2023 03 17; 4(1):102029.